Paper30809482
Comparison of topical nepafenac 0.1% with intravitreal dexamethasone implant for the treatment of Irvine-Gass syndrome.
Guclu H and 1 other. Int J Ophthalmol, 2019. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Comparison of topical nepafenac 0.1% with intravitreal dexamethasone implant for the treatment of Irvine-Gass syndrome. Papers, record 30809482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30809482
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparison of topical nepafenac 0.1% with intravitreal dexamethasone implant for the treatment of Irvine-Gass syndrome.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References64
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10360304 | The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery. | Trans Am Ophthalmol Soc | 1998 | https://conductscience.org/library/papers/10360304 | PubMed |
| 2 | 10850857 | Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacy. | Inflammation | 2000 | https://conductscience.org/library/papers/10850857 | PubMed |
| 3 | 10850858 | Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: II. In vitro bioactivation and permeation of external ocular barriers. | Inflammation | 2000 | https://conductscience.org/library/papers/10850858 | PubMed |
| 4 | 12189605 | Topical nonsteroidal antiinflammatory drugs in ophthalmology. | Int Ophthalmol Clin | 2002 | https://conductscience.org/library/papers/12189605 | PubMed |
| 5 | 12551663 | Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema. | J Cataract Refract Surg | 2003 | https://conductscience.org/library/papers/12551663 | PubMed |
| 7 | 14635785 | Inflammation-mediated retinal edema in the rabbit is inhibited by topical nepafenac. | Inflammation | 2003 | https://conductscience.org/library/papers/14635785 | PubMed |
| 8 | 15035387 | Cystoid macular edema and papilledema following cataract extraction: a fluorescein fundoscopic and angiographic study. 1966. | Retina | 2003 | https://conductscience.org/library/papers/15035387 | PubMed |
| 9 | 1549810 | Cyclo-oxygenase inhibitors in ophthalmology. | Surv Ophthalmol | 1992 | https://conductscience.org/library/papers/1549810 | PubMed |
| 10 | 16077349 | Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes. | Retina | 2005 | https://conductscience.org/library/papers/16077349 | PubMed |
| 11 | 16234444 | Non-steroidal anti-inflammatory agents for cystoid macular oedema following cataract surgery: a systematic review. | Br J Ophthalmol | 2005 | https://conductscience.org/library/papers/16234444 | PubMed |
| 12 | 16931266 | Cystoid macular edema after pars plana vitrectomy for retained lens fragments. | J Cataract Refract Surg | 2006 | https://conductscience.org/library/papers/16931266 | PubMed |
| 13 | 17016463 | Outcome of intravitreal triamcinolone acetonide in postoperative cystoid macular oedema. | Eye (Lond) | 2008 | https://conductscience.org/library/papers/17016463 | PubMed |
| 14 | 17189793 | Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery. | J Cataract Refract Surg | 2007 | https://conductscience.org/library/papers/17189793 | PubMed |
| 15 | 17397743 | Successful treatment of cystoid macular edema with valdecoxib. | J Cataract Refract Surg | 2007 | https://conductscience.org/library/papers/17397743 | PubMed |
| 16 | 17558326 | Evaluation of costs for cystoid macular edema among patients after cataract surgery. | Retina | 2007 | https://conductscience.org/library/papers/17558326 | PubMed |
| 17 | 17720069 | Clinical pseudophakic cystoid macular edema. Risk factors for development and duration after treatment. | J Cataract Refract Surg | 2007 | https://conductscience.org/library/papers/17720069 | PubMed |
| 18 | 18165084 | Efficacy of intravitreal bevacizumab in treating postoperative pseudophakic cystoid macular edema. | J Cataract Refract Surg | 2008 | https://conductscience.org/library/papers/18165084 | PubMed |
| 19 | 18599019 | A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients. | Am J Ophthalmol | 2008 | https://conductscience.org/library/papers/18599019 | PubMed |
| 20 | 18599569 | Retinal vascular caliber changes after intravitreal triamcinolone treatment for diabetic macular edema. | Invest Ophthalmol Vis Sci | 2008 | https://conductscience.org/library/papers/18599569 | PubMed |
| 21 | 18854783 | Short-term safety and efficacy of intravitreal bevacizumab for pseudophakic cystoid macular edema. | Retina | 2009 | https://conductscience.org/library/papers/18854783 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42271301 | Comparison of topical nepafenac 0.1% and 0.3% for the treatment of pseudophakic cystoid macular edema following cataract surgery. | BMC Ophthalmol | 2026 | https://conductscience.org/library/papers/42271301 | PubMed |
| 34740334 | Topical NSAIDs, intravitreal dexamethasone and peribulbar triamcinolone for pseudophakic macular edema. | BMC Ophthalmol | 2021 | https://conductscience.org/library/papers/34740334 | PubMed |
| 34640393 | Current Management Options in Irvine-Gass Syndrome: A Systemized Review. | J Clin Med | 2021 | https://conductscience.org/library/papers/34640393 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30809482
GET https://conductscience.org/api/papers/v1/30809482/references?page=2